| scholarly article | Q13442814 |
| P2093 | author name string | Xuefeng Wang | |
| Alireza R Rezaie | |||
| Likui Yang | |||
| Wenman Wu | |||
| Xiaoqing Zhao | |||
| Qiulan Ding | |||
| P2860 | cites work | Protein C Thr315Ala variant results in gain of function but manifests as type II deficiency in diagnostic assays | Q24317483 |
| Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo | Q24655664 | ||
| The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment | Q27700069 | ||
| The cytoprotective protein C pathway | Q28274500 | ||
| TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex | Q28281969 | ||
| The molecular basis of blood coagulation | Q28294854 | ||
| The dynamics of thrombin formation | Q28610129 | ||
| Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink macromolecules | Q30419776 | ||
| Rare coagulation disorders | Q33764226 | ||
| Hereditary prothrombin deficiency presenting as intracranial haematoma in infancy | Q33856058 | ||
| Activation of protein C by the thrombin-thrombomodulin complex: cooperative roles of Arg-35 of thrombin and Arg-67 of protein C | Q34304754 | ||
| Rare coagulation deficiencies. | Q34637015 | ||
| Molecular recognition in the protein C anticoagulant pathway | Q35181632 | ||
| Regulation of blood coagulation by the protein C system | Q35228533 | ||
| Polyphosphate is a cofactor for the activation of factor XI by thrombin | Q35631344 | ||
| Directing thrombin | Q36182467 | ||
| Protease-activated receptors in hemostasis, thrombosis and vascular biology | Q36230881 | ||
| Reactivities of the S2 and S3 subsite residues of thrombin with the native and heparin-induced conformers of antithrombin | Q36280817 | ||
| Cloning and analysis of a cDNA coding for bovine prothrombin | Q36405255 | ||
| Prothrombin deficiency results in embryonic and neonatal lethality in mice | Q36500463 | ||
| Signaling-mediated cooperativity between glycoprotein Ib-IX and protease-activated receptors in thrombin-induced platelet activation | Q36547814 | ||
| Factor Va alters the conformation of the Na+-binding loop of factor Xa in the prothrombinase complex | Q36737737 | ||
| Identification of a congenital dysthrombin, thrombin Quick | Q37024420 | ||
| Concentration dependent dual effect of thrombin in endothelial cells via Par-1 and Pi3 Kinase | Q37146006 | ||
| Factor XI anion-binding sites are required for productive interactions with polyphosphate. | Q37398521 | ||
| Vascular Dermatan Sulfate and Heparin Cofactor II | Q37784316 | ||
| Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis | Q39784189 | ||
| Proexosite-1 on Prothrombin Is a Factor Va-dependent Recognition Site for the Prothrombinase Complex | Q40647381 | ||
| Molecular and functional characterization of a natural homozygous Arg67His mutation in the prothrombin gene of a patient with a severe procoagulant defect contrasting with a mild hemorrhagic phenotype | Q40714431 | ||
| A novel prothrombin mutation in two families with prominent thrombophilia--the first cases of antithrombin resistance in a Caucasian population | Q44640754 | ||
| Molecular defect of 'Prothrombin Amrita': substitution of arginine by glutamine (Arg553 to Gln) near the Na(+) binding loop of prothrombin | Q45179671 | ||
| Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias | Q45873378 | ||
| New Prothrombin Mutation (Arg596Trp, Prothrombin Padua 2) Associated With Venous Thromboembolism | Q45884368 | ||
| Substitution of Gly-548 to Ala in the substrate binding pocket of prothrombin Perijá leads to the loss of thrombin proteolytic activity. | Q50143652 | ||
| Rescue of prothrombin-deficiency by transgene expression in mice. | Q52110188 | ||
| The conversion of prothrombin to thrombin. V. The activation of prothrombin by factor Xa in the presence of phospholipid. | Q54702028 | ||
| Prothrombin Himi: a compound heterozygote for two dysfunctional prothrombin molecules (Met-337-->Thr and Arg-388-->His) | Q67919366 | ||
| Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix | Q70751733 | ||
| Genetic analysis and functional characterization of prothrombins Corpus Christi (Arg382-Cys), Dhahran (Arg271-His), and hypoprothrombinemia | Q71611763 | ||
| Protein C Inhibitor Is a Potent Inhibitor of the Thrombin-Thrombomodulin Complex | Q71823602 | ||
| Molecular events that control the protein C anticoagulant pathway | Q72595211 | ||
| Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin | Q73503901 | ||
| Role of proexosite I in factor Va-dependent substrate interactions of prothrombin activation | Q73626480 | ||
| Elements of the primary structure of thrombomodulin required for efficient thrombin-activable fibrinolysis inhibitor activation | Q73762875 | ||
| Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation | Q77647784 | ||
| Congenital deficiencies and abnormalities of prothrombin | Q77719013 | ||
| Thrombosis from a prothrombin mutation conveying antithrombin resistance | Q84420305 | ||
| P433 | issue | 3 | |
| P921 | main subject | homozygosity | Q114049690 |
| P304 | page(s) | 479-490 | |
| P577 | publication date | 2016-12-15 | |
| P1433 | published in | Thrombosis and Haemostasis | Q15724413 |
| P1476 | title | Paradoxical bleeding and thrombotic episodes of dysprothrombinaemia due to a homozygous Arg382His mutation. | |
| P478 | volume | 117 |
Search more.